Effects of Ketoconazole on the Pharmacokinetics of Ponatinib in Healthy Subjects

Trial Profile

Effects of Ketoconazole on the Pharmacokinetics of Ponatinib in Healthy Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 20 Aug 2013

At a glance

  • Drugs Ponatinib (Primary) ; Ketoconazole
  • Indications Acute lymphoblastic leukaemia; Chronic myeloid leukaemia
  • Focus Pharmacokinetics
  • Most Recent Events

    • 20 Aug 2013 New trial record
    • 25 Jun 2013 Results published in the Journal of Clinical Pharmacology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top